Backgrounds Locally invasive T4 rectal cancer often requires neoadjuvant treatment
followed by multi‐visceral surgery to achieve a radical resection (R0), and referral to a …

Introduction Local excision is increasingly used as an alternative treatment for radical
surgery in patients with early stage clinical T1 (cT1) rectal cancer. This study provides an …

Background Rectal cancer treatment outcomes for socioeconomically disadvantaged and
regional patients have been suggested to be suboptimal in Australia. We investigate …

BACKGROUND: A more extensive resection is often required in locally advanced rectal
cancer, depending on preoperative neoadjuvant treatment response. OBJECTIVE …

Purpose Primary local excision (PLE) for early rectal cancers is associated with decreased
surgical morbidity and mortality compared with major resection (MR). However, it is thought …

Background Clinically staged T1-3 rectal cancer (cT1-3) is generally treated by total
mesorectal excision (TME) with or without neoadjuvant therapy and sometimes requires …

Aim Significant recent changes in management of locally advanced rectal cancer (LARC)
include preoperative staging, use of extended neoadjuvant therapies and minimally invasive …

Background Local resection (LR) methods for rectal cancer are generally considered in the
palliative setting or for patients deemed a high anaesthetic risk. This systematic review and …

BACKGROUND: Rectal cancer outcomes have improved with the adoption of a
multidisciplinary model of care. However, there is a spectrum of quality when viewed from a …

Purpose Surgical approach to rectal cancer has evolved in recent decades, with introduction
of minimally invasive surgery (MIS) techniques and local excision. Since implementation …